Maria Ramirez

Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2.

P. Walker, D. Liles, H. Elsamaloty, 2006, Cancer biotherapy & radiopharmaceuticals.

Correlation between development of pulmonary edema and response of pulmonary metastases of metastatic melanoma and kidney cancer to high-dose continuous-infusion interleukin-2.

P. Walker, M. Vinogradov, Nawazish Khan, 2005, Cancer biotherapy & radiopharmaceuticals.

High-dose continuous infusion plus pulse interleukin-2 and famotidine in metastatic kidney cancer.

M. Vinogradov, Nawazish Khan, Chris Taylor, 2005, Cancer biotherapy & radiopharmaceuticals.

Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.

P. Walker, M. Vinogradov, Chris Taylor, 2005, Cancer biotherapy & radiopharmaceuticals.

High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma.

Shawn B. Jackson, M. Vinogradov, Nawazish Khan, 2004, Cancer biotherapy & radiopharmaceuticals.